GE Healthcare Joins Personalized Medicine Fray, Seeks Drug Firm Alliances
This article was originally published in The Gray Sheet
GE Healthcare's pursuit of personalized medicine through the April 8 integration of Amersham likely will involve co-development agreements with large pharmaceutical firms
You may also be interested in...
Siemens Medical Solutions has initiated marketing of Somatom Sensation 64 and Sensation Open computed tomography (CT) systems, which are slated to ship in November
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.